Initial Experience Using 99mTc-Mibi SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma

Clinical Nuclear Medicine - United States
doi 10.1097/rlu.0000000000000670
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Initial Experience of SPECT/CT in the Diagnosis of Occult Scaphoid Fracture

Acta Radiologica Open
2015English

Comparative Cytological Evaluation of Renal Oncocytoma and Renal Cell Carcinoma in the Same Kidney.

The Journal of the Japanese Society of Clinical Cytology
1994English

SPECT/CT Activity Quantification in 99mTc-Maa Acquisitions.

Journal of Diagnostic Imaging in Therapy
2018English

Spect/Ct With 99mtc-Mibl in Monitoring of Esthesioneuroblastoma

Siberian Journal of Oncology
Cancer ResearchOncology
2017English

99mTc-Hmpao Perfusion SPECT/CT in the Diagnosis of Brain Death

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2016English

Bromocriptine Enhances the Uptake of 99mTc-Mibi in Patients With Hepatocellular Carcinoma

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2012English

Mp78-13 Prospective Evaluation of 99mtc-Sestamibi Spect/Ct for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors

Journal of Urology
Urology
2016English

Systematic Evaluation of Tumoral 99mTc-Maa Uptake Using SPECT and SPECT/CT in 502 Patients Before 90Y Radioembolization

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Parathyroid Scintigraphy in Patients With Primary Hyperparathyroidism:99mTc Sestamibi SPECT and SPECT/CT

Radiographics
MedicineNuclear MedicineRadiologyImaging
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy